PHARMACOLOGY OF GR203040, A POTENT AND SELECTIVE NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST

被引：0
|
作者：
BEATTIE, DT
CONNER, HE
HAWCOCK, AB
PERREN, MJ
WARD, P
机构：
[1] GLAXO RES & DEV LTD,DEPT PHARMACOL,STEVENAGE SG1 2NY,HERTS,ENGLAND
[2] GLAXO RES & DEV LTD,DEPT MED CHEM,STEVENAGE SG1 2NY,HERTS,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [31] NEW SPIROPIPERIDINES AS POTENT AND SELECTIVE NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONISTS
    SMITH, PW
    COOPER, AWJ
    BELL, R
    BERESFORD, IJM
    GORE, PM
    MCELROY, AB
    PRITCHARD, JM
    SAEZ, V
    TAYLOR, NR
    SHELDRICK, RLG
    WARD, P
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (19) : 3772 - 3779
  • [32] CP-99,994, A NONPEPTIDE ANTAGONIST OF THE TACHYKININ NK(1) RECEPTOR
    MCLEAN, S
    SNIDER, RM
    DESAI, MC
    ROSEN, T
    BRYCE, DK
    LONGO, KP
    SCHMIDT, AW
    HEYM, J
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 329 - 331
  • [33] Pharmacological profiles of new orally active nonpeptide tachykinin NK1 receptor antagonists
    Hosoki, R
    Yanagisawa, M
    Onishi, Y
    Yoshioka, K
    Otsuka, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) : 235 - 241
  • [34] Pharmacology of men 11467, a potent, selective and orally effective pseudopeptide tachykinin NK-1 antagonist
    Cirillo, R
    Astolfi, M
    Ciucci, A
    Palma, C
    Parlani, M
    Lopez, G
    Conte, B
    Terracciano, R
    Fincham, CI
    Sisto, A
    Maggi, CA
    Manzini, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R324 - R324
  • [35] A POTENT AND SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROKININ-A (NK2) RECEPTOR
    EMONDSALT, X
    VILAIN, P
    GOULAOUIC, P
    PROIETTO, V
    VANBROECK, D
    ADVENIER, C
    NALINE, E
    NELIAT, G
    LEFUR, G
    BRELIERE, JC
    LIFE SCIENCES, 1992, 50 (15) : PL101 - PL106
  • [36] GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity
    Gardner, CJ
    Armour, DR
    Beattie, DT
    Gale, JD
    Hawcock, AB
    Kilpatrick, GJ
    Twissell, DJ
    Ward, P
    REGULATORY PEPTIDES, 1996, 65 (01) : 45 - 53
  • [37] PERHYDROTHIOPYRANOPYRROLES DERIVATIVES - A NOVEL SERIES OF POTENT AND SELECTIVE NONPEPTIDE NK1 ANTAGONISTS
    ACHARD, D
    TRUCHON, A
    PEYRONEL, JF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (05) : 669 - 672
  • [38] The airways pharmacology of DNK333, a potent, selective, non-peptide dual NK1/NK2 receptor antagonist
    Lewis, CA
    El-Hashim, AZ
    Gerspacher, M
    Hoshiko, K
    Mazzoni, L
    Pfannkuche, HJ
    Subramanian, N
    Fozard, JR
    DRUG DEVELOPMENT RESEARCH, 2004, 63 (04) : 161 - 173
  • [39] ANALOGS OF GR159897 A HIGHLY POTENT NONPEPTIDE NK2 RECEPTOR ANTAGONIST
    COX, B
    ADAMS, HS
    BELL, R
    COOPER, AWJ
    GORE, PM
    PRITCHARD, JM
    SAEZ, V
    WARD, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 58 - MEDI
  • [40] Discovery of an orally bioavailable NK1 receptor antagonist, (2S,3S)-(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with potent antiemetic activity
    Ward, P
    Armour, DR
    Bays, DE
    Evans, B
    Giblin, GMP
    Heron, N
    Hubbard, T
    Liang, K
    Middlemiss, D
    Mordaunt, J
    Naylor, A
    Pegg, NA
    Vinader, MV
    Watson, SP
    Bountra, C
    Evans, DC
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) : 4985 - 4992
12345